
(F4) Treatment of high risk myelodysplastic syndromes with sequential intermediate dose cytosine arabinoside and mitoxantrone (S-HAM) with or without GM-CSF: A prospective double blinded randomised study
W Hiddemann, T.H. Buchner, B Wormann, P Koch, C Aul, M Andreeff, J.M. BennettVolume:
15
Année:
1991
Langue:
english
DOI:
10.1016/0145-2126(91)90373-2
Fichier:
PDF, 154 KB
english, 1991